The Company was incorporated as ÂEris Lifescience Private Limited on January 25, 2007, as a private limited company under the Companies Act 1956, at Ahmedabad, with a certificate of incorporation granted by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Pursuant to a resolution of the Shareholders dated February 5, 2007, the name of the Company was changed to ÂEris Lifesciences Private Limited and a fresh certificate of incorporation was issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli on February 9, 2007. Further, pursuant to a conversion of the Company to a public limited company, and as approved by the Shareholders through a resolution dated January 31, 2017, the name was changed to ÂEris Lifesciences Limited and the RoC issued a fresh certificate of incorporation on February 2, 2017.
Major events and milestones
The table below sets forth some of the major events in the history of the Company.
2007
-Incorporation of the Company
-Launched ÂEris division focused on cardiology and diabetes segment
2008
-Launched ÂNikkos division focused on gastroenterology and orthopedics segment
2009
-Launched ÂAdura division focused on cardiology and diabetes segment
2011
-Launched ÂMontana division focused on gynecology and pediatrics segment
2012
-Launched ÂInspira division focused on cardiology segment
2013
-Awarded 'Competitive Strategy Leadership' award by Frost & Sullivan
-Awarded 'Emerging Companies Excellence' award for scalability of business model and managing operational efficiencies by Business Today and Yes Bank
2014
-Launched ÂVictus division focused on anti-diabetes segment
-Set up Assam Facility by the Company
2015
-Launched ÂEris 2Â division focused on pain management segment
2016
-Acquired 40 registered and unregistered trademarks from Amay Pharmaceuticals Private Limited (now, Aprica Pharmaceuticals Private Limited)
-Acquired 100.00% of the outstanding equity shares of Aprica Healthcare Private Limited
-Acquired 75.48% of the outstanding equity shares of Kinedex Healthcare Private Limited
2017
-Acquired the trademarks ÂUNIONÂ, ÂREUNIONÂ and ÂBON UNIONÂ
2022
-Eris Enters Dermatology Therapy Through The Acquisition Of Oaknet Healthcare For Inr 6,500 Mn.Â
2023Â
 -""Eris announces the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics in India"".Â
2024Â
 -The Company informed the Exchange about the acquisition of 30% stake in Levim Lifetech Private Limited.Â
-The Company Informed acquisition of 100% stake in Eris Pharmaceuticals Private Limited.